Actinic keratosis: An occupational and environmental disorder

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 606-615

  Schwartz, R A ^a   Bridges, T M ^b   Butani, A K ^a   Ehrlich, A ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Actinic keratosis; Carcinogenesis; Occupational disease; Squamous cell carcinoma; Ultraviolet light

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); DICLOFENAC; FLUOROURACIL; IMIQUIMOD; LIQUID NITROGEN; RETINOID; SUNSCREEN;

ACTINIC KERATOSIS; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; DIFFERENTIAL DIAGNOSIS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEALTH PROMOTION; HEREDITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LATITUDE; MORBIDITY; OCCUPATIONAL HAZARD; OCCUPATIONAL SKIN DISEASE; PATHOGENESIS; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SKIN CARCINOMA; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; KERATOSIS; MALE; OCCUPATIONAL EXPOSURE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 42149133572     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02579.x     Document Type: Article

References (79)

1. Vitasa BC, Taylor HR, Strickland PT et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65: 2811-2817.
2. Vishvakarman D, Wong JCF, Borehan BW. Annual occupational exposure to ultraviolet radiation in central Queensland. Health Physics 2001; 81: 536-544.
3. Warino L, Tusa M, Camacho F, Teuschler H, Fleischer AB Jr, Feldman SR. Frequency and cost of actinic keratosis treatment. Dermatol Surg 2006; 32: 1045-1049.
4. Schwartz RA. Actinic keratosis: Perspective and update. Dermatol Surg 1997; 23: 1009-1019.
5. Hurwitz RM, Monger LE. Solar keratosis: An evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995; 21: 183.
6. Unna PG. Die Histopathologie der Hautkrankheiten. Verlag von August Hirschwald, Berlin, 1894: 719-724.
7. Dubreuilh W. Des hyperkeratoses circonscrites. In: Pringle JJ, ed. Third International Congress of Dermatology Held in the Examination Hall of the Conjoint Royal Colleges of Physicians and Surgeons. London, August 4th to 8th, 1896. Official Transactions. Waterlow and Sons Limited, London, 1898: 125-176.
8. Hyde JN. On the influence of light in the production of cancer of the skin. Am J Med Sci 1906; 131: 1-22.
9. Freudenthal W. Verruca senilis und Keratoma senile. Arch f Dermat u Syph (Berlin). 1926; 152: 505-528.
10. Lambert WC, Schwartz RA. Evidence for origin of basal cell carcinoma in solar (actinic) keratoses. J Cutan Pathol 1988; 15: 322.
11. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: S23-S24.
12. Marks R, Rennie G, Selwood TS. The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses. Arch Dermatol 1988; 124: 1039-1042.
13. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: The case for conservative management. Br J Dermatol 1986; 115: 649-655.
14. Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol 1996; 35: 223-242.
15. Schwartz RA, Stoll HL Jr. Epithelial precancerous lesions. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, 1999: 823-839.
16. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22.
17. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S11-S17.
18. Montgomery H, Dörffel J. Verruca senilis und keratoma senile. Arch f Dermat u Syphil (Berlin) 1932; 166: 286-297.
19. Unna PG. Über das Wesen der normalen und pathologischen Verhornung. In: Pringle JJ, ed. Third International Congress of Dermatology Held in the Examination Hall of the Conjoint Royal Colleges of Physicians and Surgeons. London, August 4th to 8th, 1896. Official Transactions. Waterlow and Sons Limited, London, 1898: 95-118.
20. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-464.
21. de Rooij MJM, Rampen FHJ, Schouten LJ, Neumann HA. Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 1995; 131: 422-425.
22. Silverstone H, Campbell CB, Hosking CB et al. Regional studies in skin cancer. First report: North-western Queensland. Med J Austral 1963; 1: 312-315.
23. Zagula-Mally ZW, Rosenberg EW, Kashgarian M. Frequency of skin cancer and solar keratoses in a rural southern county as determined by population sampling. Cancer 1974; 34: 345-349.
24. Holmes C, Foley P, Freeman M, Chong AH. Solar keratosis: Epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol 2007; 48: 67-74.
25. Beirn SF, Judge P, Urbach F, MacCon CF, Martin F. Skin cancer in County Galway, Ireland. Proc Natl Cancer Conf 1970; 6: 489-500.
26. Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139: 1033-1039.
27. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J 1988; 296: 13-17.
28. Marks R, Jolley D, Lectsas S, Foley P. The role of childhood exposure to sunlight in the development of solar keratoses and non-melanoma skin cancer. Med J Aust 1990; 152: 62-66.
29. Serrano H, Scotto J, Shornick G, Fears TR, Greenberg ER. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont. J Am Acad Dermatol 1991; 24: 574-579.
30. Budhwar R, Bihari V, Mathur N, Srivastava A, Kumar S. DNA-protein crosslinks as a biomarker of exposure to solar radiation: A preliminary study in brick-kiln workers. Biomarkers 2003; 8: 162-166.
31. Nelson MA, Einspahr JG, Alberts DS et al. Analysis of p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 1994; 85: 23-29.
32. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995; 131: 796-800.
33. Dinehart SM, Nelson-Adesokan P, Cockerell C, Russell S, Brown R. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997; 79: 920-923.
34. Freeman RG, Barr RJ, Elder DE. What is the boundary that separates a thick solar keratosis from a thin squamous cell carcinoma? Am J Dermatopathol 1984; 6: 301-306.
35. Kiyokane K, Sakatani S, Kusakabe H et al. A statistical study on clinical findings of solar keratosis. J Med 1992; 23: 389-398.
36. Tejera-Vaqueriz A, Solís-García E, Sanchez-Vizcaino J, Segura J, Vazquez MC, Haro V, Gonzalez T. Proliferative actinic keratosis. J Eur Acad Dermatol Venereol 2007; 21: 1289-1291.
37. Pock L, Drlík L, HercogováJ. Dermatoscopy of pigmented actinic keratosis -a striking similarity to lentigo maligna. Int J Dermatol 2007; 46: 414-416.
38. Mencía-Gutiérrez E, Gutiérrez-Diaz E, Redondo-Marcos I, Ricoy Jr, García-Torre JP. Cutaneous horns of the eyelid: A clinicopathological study of 48 cases. J Cutan Pathol 2004; 31: 539-543.
39. Markopoulous A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004; 10: 212-216.
40. Boddie AW Jr, Pischer EP, Byers RM. Squamous carcinoma of the lower lip in patients under 40 years of age. South Med J 1977; 70: 711-712, 715.
41. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001; 12: 552-557.
42. Calderone DC, Fenske NA. The clinical spectrum of actinic elastosis. J Am Acad Dermatol 1995; 32: 1016-1024.
43. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-1151.
44. Fitzpatrick TB. The skin cancer cascade; from ozone depletion to melanoma -some definitions and some new interpretations. J Dermatol (Tokyo) 1996; 23: 816-820.
45. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029-1031.
46. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-797.
47. Gies P, Wright J. Measured solar ultraviolet radiation exposures of outdoor workers in Queensland in the building and construction industry. Photochem Photobiol 2003; 78: 342-348.
48. Bridges T, Ehrlich A. Assessment of behavior and knowledge concerning sun protection and skin cancer risks in Maryland watermen. [Abstract] J Am Acad Dermatol 2005; 52 (Suppl. 1): P102.
49. Lambert WC, Lambert MW. DNA repair deficiency and skin cancer in xeroderma pigmentosum. In: Mukhtar H, eds. Skin Cancer: Mechanisms and Human Relevance. CRC Press, Boca Raton, 1995: 39-70.
50. Lennard L, Thomas S, Harrington C, Maddocks JL. Skin cancer in renal transplant recipients is associated with increased concentration of 6-thioguanine nucleotide in red blood cells. Br J Dermatol 1985; 113: 723-729.
51. Black HS, Herd JA, Goldberg LH et al. Effect of a low-fat diet on the incidence of actinic keratosis. New Engl J Med 1994; 330: 1272-1275.
52. Graham G, Graham J. Solar keratosis with squamous cell carcinoma (SK-SCC). J Cutan Pathol 1997; 24: 100.
53. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000; 42: S25-S28.
54. Gold M. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J Drugs Dermatol 2008; 7: 23-25.
55. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982; 7: 631-663.
56. Jorizzo J, Weiss J, Furst K, Vandepol C, Levy SF. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: A randomized, vehicle-controlled clinical trial. Arch Dermatol 2004; 140: 813-816.
57. Stockfleth E, Meyer T, Benninghoff B et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-1502.
58. de Berker D, McGregor JM, Hughes BR. Guidelines for the management of actinic keratoses. Brt J Dermatol 2007; 156: 222-230.
59. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J Am Acad Dermatol 2002; 47: S571-S577.
60. Merk HF. Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 2007; 46: 12-18.
61. Szeimies RM, Gerritsen MJ, Gupta G et al. Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004; 51: 547-555.
62. Rivers JJ, Wolf J. Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel. Acta Derm Venereol 2007; 87: 188-189.
63. Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 2004; 3: 401-407.
64. Merk HF. Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 2007; 46: 12-18.
65. Piacquadio DJ, Chen DM, Farber HF et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004; 140: 41-46.
66. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40.
67. Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. J Am Acad Dermatol 2007; 56: 125-143.
68. Barta U, Grafe T, Wollina U. Radiation therapy for extensive actinic keratosis. J Eur Acad Dermatol Venereol 2000; 14: 293-295.
69. Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: Update. Part 2: Clinical results. J Eur Acad Dermatol Venereol 2007 2006; 21: 439-451.
70. Schwartz RA. Skin Cancer. Recognition and Management, 2nd edn. Blackwell, Oxford, United Kingdom, 2008.
71. Klein E, Schwartz RA, Case RW et al. Accessible tumors. In: LoBuglio AF, ed. Clinical Immunotherapy. Marcel Dekker, Inc., New York, 1980: 31-71.
72. Klein E, Stoll HL Jr, Milgrom H, Helm F, Walker MJ. Tumors of the skin. XII. Topical 5-Fluorouracil for epidermal neoplasms. J Surg Oncol 1971; 3: 331-349.
73. Klein E. Local chemotherapy of cutaneous neoplasms. Proc Natl Cancer Conf 1970; 6: 501-515.
74. Klein E. Tumors of skin. IX. Local cytostatic therapy of cutaneous and mucosal premalignant and malignant lesions. N Y State J Medical 1968; 68: 886-889.
75. Tanghetti E, Werschler P. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp. J Drugs Dermatol 2007; 6: 144-147.
76. Geller AC, Cantor M, Kenausis K et al. The Environmental Protection Agency's National SunWise School Program: 1999-2000. J Am Acad Dermatol 2002; 46: 683-689.
77. MacKie RM. Awareness, knowledge, and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J Eur Acad Dermatol Venereol 2004; 18: 552-555.
78. Esmann S, Jemec GB. Management of actinic keratoses patients: A qualitative study. J Dermatol Treat 2007; 18: 53-58.
79. Smith K, Hamza S, Germain M, Skelton H. Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin? Dermatol Surg 2007; 33: 1419-1428; discussion 1428-1429 by Micali G, Schwartz RA.